PMC:7128678 / 916-1126 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"48","span":{"begin":102,"end":107},"obj":"Gene"},{"id":"60","span":{"begin":68,"end":80},"obj":"Chemical"},{"id":"61","span":{"begin":138,"end":150},"obj":"Chemical"},{"id":"62","span":{"begin":179,"end":191},"obj":"Chemical"}],"attributes":[{"id":"A48","pred":"tao:has_database_id","subj":"48","obj":"Gene:59272"},{"id":"A61","pred":"tao:has_database_id","subj":"61","obj":"MESH:D012794"},{"id":"A62","pred":"tao:has_database_id","subj":"62","obj":"MESH:D005732"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ffers several potential therapeutic targets. The S protein uses the angiotension-converting enzyme-2 (ACE-2) receptor for entry, but also sialic acids linked to host cell surface gangliosides. Using a combinati"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T30","span":{"begin":49,"end":58},"obj":"PG_1"},{"id":"T31","span":{"begin":102,"end":107},"obj":"G_3;PG_10;PR:000003622"},{"id":"T32","span":{"begin":138,"end":144},"obj":"CHEBI:30563;CHEBI:30563"},{"id":"T33","span":{"begin":145,"end":150},"obj":"CHEBI:41865;CHEBI:41865"},{"id":"T34","span":{"begin":161,"end":178},"obj":"GO:0044228"},{"id":"T35","span":{"begin":179,"end":191},"obj":"CHEBI:28892;CHEBI:28892"}],"text":"ffers several potential therapeutic targets. The S protein uses the angiotension-converting enzyme-2 (ACE-2) receptor for entry, but also sialic acids linked to host cell surface gangliosides. Using a combinati"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T3","span":{"begin":51,"end":58},"obj":"Body_part"},{"id":"T4","span":{"begin":166,"end":178},"obj":"Body_part"},{"id":"T5","span":{"begin":166,"end":170},"obj":"Body_part"},{"id":"T6","span":{"begin":179,"end":191},"obj":"Body_part"}],"attributes":[{"id":"A3","pred":"fma_id","subj":"T3","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A4","pred":"fma_id","subj":"T4","obj":"http://purl.org/sig/ont/fma/fma67653"},{"id":"A5","pred":"fma_id","subj":"T5","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A6","pred":"fma_id","subj":"T6","obj":"http://purl.org/sig/ont/fma/fma82816"}],"text":"ffers several potential therapeutic targets. The S protein uses the angiotension-converting enzyme-2 (ACE-2) receptor for entry, but also sialic acids linked to host cell surface gangliosides. Using a combinati"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T5","span":{"begin":166,"end":170},"obj":"http://purl.obolibrary.org/obo/GO_0005623"},{"id":"T6","span":{"begin":199,"end":200},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"ffers several potential therapeutic targets. The S protein uses the angiotension-converting enzyme-2 (ACE-2) receptor for entry, but also sialic acids linked to host cell surface gangliosides. Using a combinati"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T10","span":{"begin":51,"end":58},"obj":"Chemical"},{"id":"T11","span":{"begin":138,"end":150},"obj":"Chemical"},{"id":"T12","span":{"begin":145,"end":150},"obj":"Chemical"},{"id":"T13","span":{"begin":179,"end":191},"obj":"Chemical"}],"attributes":[{"id":"A10","pred":"chebi_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"},{"id":"A11","pred":"chebi_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/CHEBI_26667"},{"id":"A12","pred":"chebi_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/CHEBI_37527"},{"id":"A13","pred":"chebi_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/CHEBI_28892"}],"text":"ffers several potential therapeutic targets. The S protein uses the angiotension-converting enzyme-2 (ACE-2) receptor for entry, but also sialic acids linked to host cell surface gangliosides. Using a combinati"}

{"project":"LitCovid-sentences","denotations":[{"id":"T12","span":{"begin":45,"end":192},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"ffers several potential therapeutic targets. The S protein uses the angiotension-converting enzyme-2 (ACE-2) receptor for entry, but also sialic acids linked to host cell surface gangliosides. Using a combinati"}